QuickVue Adenoviral conjunctivits



Adenoviral conjunctivits

Eye health
Point-of-Care Testing for Acute Conjunctivitis

Acute conjunctivitis – more commonly known as “pink eye” – affects nearly 6.9 million people in the United States every year. Approximately 1 in 4 patients with acute conjunctivitis have confirmed adenoviral conjunctivitis. QuickVue Adenoviral conjunctivits Test is the first and only CLIA-waived, point-of-care test that detects all known serotypes of adenoviral conjunctivitis.

Early and accurate diagnosis of pink eye may prevent serious consequences including morbidity. Significant overlap exists in the clinical signs and symptoms of acute conjunctivitis and misdiagnosis by eye care professionals occurs in approximately 50% of conjunctivitis cases. With QuickVue Adenoviral conjunctivits Test you can make a rapid, accurate diagnosis before the patient leaves your office.

Feature Benefit
Sample collector Sterile sampling fleece allows for a small fluid sample to be tested
Results in 10 minutes Test and treat in the same office visit
Identifies subclinical findings Eliminates guess work, confirms diagnosis
One reagent Few steps, easy to perform, require minimal training
Two-color result Easy to read and interpret
All components included in kit Ready to use, no need for additional equipment
External controls included Facilitates internal laboratory quality control
Room temperature storage No need for refrigeration, can be stored in exam rooms
Sample type Tear fluid
Time to results 10 minutes
Kit storage conditions Room temperature (15°C to 35°C / 59°F to 86°F)
External Controls Positive and negative
Sensitivity* 90%
Specificity* 96%
Shelf life 30 months from date of manufacture
CLIA complexity Waived

* For more information about QuickVue Adenoviral conjunctivits Test Click Here